drugset / Trial / NCT01106716

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia

NCT01106716

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether KAI-1678 is effective in the treatment of postherpetic neuralgia pain

Timeline

Start
2009-03
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject KAI-1678 Unknown Intravenous
Comparator Lidocaine Other / unclassified